In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
about
Peptide Vaccine: Progress and ChallengesIntranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challengeFormulation and characterization of a plasma sterilized, pharmaceutical grade chitosan powderA randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineChitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model.Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospectsCurrent understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges.Biodegradable chitosan nanoparticles in drug delivery for infectious disease.Recombinant Vaccines: Development, Production, and Application
P2860
Q26851329-E80ACBDB-10D9-46E4-AC4C-2BDCE325B631Q27345256-5317A447-6327-4E14-BB54-50E1FAEDFFB6Q33467779-32C67B9B-852A-4D79-B040-9D151F6D1F83Q33606083-C30EACE4-6A18-4520-A6BD-E8EC4811BCB4Q33612179-C19F5B9C-0BD4-4716-8BE9-EE12A3E40162Q34033764-51BE7D5F-AAA4-4EF6-9D93-E251B12A227AQ35750626-A9BDB8F1-7BDF-4E41-ACE7-7FF980A6A9D7Q36582241-D30EE6A1-FEF2-4118-9502-7E25E42DFD18Q36702887-5B0B18D0-2C4B-4623-8364-077260042A68Q37132243-D51F12DB-9BE3-4D93-8224-4E105829FA9CQ37286061-DEED1C4C-BF6E-4A83-AD0A-AC4B8BE23CE6Q38362427-0DEA70AE-7A05-4199-83FD-6149A2287240Q38501659-BF17DCEB-46F4-46FC-94D8-9E08D4EB087FQ56936206-6B4D5CB1-C994-4050-8EFE-4FA04BA83D17
P2860
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@ast
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@en
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@nl
type
label
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@ast
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@en
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@nl
prefLabel
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@ast
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@en
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@nl
P2093
P2860
P1433
P1476
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
@en
P2093
Jeffrey Schlom
John W Greiner
Jonathan K Fallon
Michael J Heffernan
P2860
P304
P356
10.1016/J.BIOMATERIALS.2010.09.058
P577
2010-10-20T00:00:00Z